News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Nicole Chmielewski-Stivers

Articles by Nicole Chmielewski-Stivers

33 MammaPrint® and BluePrint® Predict Anthracycline Chemosensitivity in Patients With HR+HER2– Early-Stage Breast Cancer Enrolled in FLEX

33 MammaPrint® and BluePrint® Predict Anthracycline Chemosensitivity in Patients With HR+HER2– Early-Stage Breast Cancer Enrolled in FLEX

ByWilliam Audeh, MD,Nicole Chmielewski-Stivers,Harshini Ramaswamy,Andrea Menicucci

June 30th 2024

Latest Updated Articles

Trending on CancerNetwork

Daraxonrasib Shows "Unprecedented" Survival in Pretreated Pancreatic Cancer

Impact of IGNYTE Trial Responses to RP1/Nivolumab in Advanced Melanoma

Navigating Proton Therapy, Immunotherapy Sequencing, and AI in HNC

FDA Receives sBLA for Zenocutuzumab in Advanced NRG1+ Cholangiocarcinoma

I-DXd Earns FDA Priority Review in Extensive-Stage Small Cell Lung Cancer